Is this you? Create Your Porfile
Avatar

Douglas F. Nixon

San Francisco General Hospital

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Douglas F. Nixon is active.

Explore More

Publication

Featured researches published by Douglas F. Nixon.

Clinical Immunology | 2008

Su.44. IL-10-Producing HIV-Specific T Cells Have Suppressive Properties

Eirik A. Torheim; Lishomwa Ndhlovu; Aashish R. Jha; Frank Olav Pettersen; Dag Kvale; Douglas F. Nixon; Kjetil Taskén; Einar Martin Aandahl

Archive | 2018

Characterization of ERV9 Elements within the Human Genome

Keylie M. Gibson; Gary A. Hovsepian; Miguel de Mulder; R. Brad Jones; Keith A. Crandall; Douglas F. Nixon; Matthew L. Bendall

Archive | 2017

Single locus resolution of transposable element expression using RNA-seq

Matthew L. Bendall; Miguel de Mulder Rougvie; Aarón Lecanda-Sánchez; Marcos Pérez-Losada; Mario Ostrowski; R. Brad Jones; Lubbertus C. Miller; Gustavo Reyes-Terán; Keith A. Crandall; Christopher E. Ormsby; Douglas F. Nixon

Archive | 2014

Cytotoxicity on HIV-1 Mediates Antibody-Dependent Cellular Ancestral Endogenous Virus Glycoproteins Cutting Edge: An Antibody Recognizing

Jonah B. Sacha; Douglas F. Nixon; Steven G. Deeks; Jeffrey N. Martin; Devi SenGupta

Archive | 2013

LINE-1 Retrotransposable Elem ent DNA Accumulates in HIV-1-

R. Brad Jones; Haihan Song; Yang Xu; Keith Garrison; Anton Buzdin; Naveed Anwar; Diana V. Hunter; Shariq Mujib; Vesna Mihajlovic; Eric Martin; Erika Lee; Monika Kuciak; Rui André; Saraiva Raposo; Ardalan Bozorgzad; Duncan A. Meiklejohn; C Lishomwa; Douglas F. Nixon; Mario Ostrowski

Archive | 2013

Infection Is Critically Influenced by Age and Children with Vertically Acquired HIV-1 HIV-Specific CD8+ T Cell Function in

G. Rosenberg; Douglas F. Nixon; Hans Spiegel; Andrew Wiznia; N. Furlan; Jason D. Barbour; Glenn J. Fennelly; K. Sandberg; Noam M. Fast; Kimberly A. Jordan

Archive | 2013

infection treated with interleukin-2 Expansion of CD1d-restricted NKT cells in patients with primary HIV-1

Douglas F. Nixon; Markus Moll; Jennifer E. Snyder-Cappione; Gerald Spotts; Frederick M Hecht; Johan K. Sandberg

Archive | 2012

Human endogenous retrovirus peptides, antibodies to the peptides, and methods of use thereof

Douglas F. Nixon; Henri-Alexandre Michaud; Steven G. Deeks; Jonah B. Sacha; R. Bradley Jones; Mario Ostrowski

Archive | 2012

cell-mediated cytotoxicity Tim-3 marks human natural killer cell maturation and suppresses

Eric C. Schoeffler; Tsuyoshi Fujita; Douglas F. Nixon; Lewis L. Lanier; Lishomwa C. Ndhlovu; Jason D. Barbour; R. Brad Jones; Aashish R. Jha

Archive | 2008

Méthodes thérapeutiques et diagnostiques utilisant le tim-3

Richard Bradley Jones; Mario Ostrowski; Douglas F. Nixon; Lishomwa C. Ndhlovu; James M. Rini

Explore More

Collaboration

Dive into the Douglas F. Nixon's collaboration.

Top Co-Authors
Avatar

Mario Ostrowski

Albert Einstein College of Medicine

View shared research outputs
Top Co-Authors
Avatar

R. Brad Jones

George Washington University

View shared research outputs
Top Co-Authors
Avatar

Aashish R. Jha

San Francisco General Hospital

View shared research outputs
Top Co-Authors
Avatar

Duncan A. Meiklejohn

University of California

View shared research outputs
Top Co-Authors
Avatar

Frederick M Hecht

University of California

View shared research outputs
Top Co-Authors
Avatar

Jason D. Barbour

University of Hawaii at Manoa

View shared research outputs
Top Co-Authors
Avatar

Jonah B. Sacha

Oregon Health

View shared research outputs
Top Co-Authors
Avatar

Keith Garrison

Albert Einstein College of Medicine

View shared research outputs
Top Co-Authors
Avatar

Lishomwa C. Ndhlovu

University of Hawaii

View shared research outputs
Top Co-Authors
Avatar

Matthew L. Bendall

Brigham Young University

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge